| Trial ID: | L0523 |
| Source ID: | IRCT201703194010N18
|
| Associated Drug: |
Citrulline
|
| Title: |
The effect of citrulline supplementation on serum lipids, liver enzymes, inflammatory markers and hepatic steatosis in patient with nonalcoholic fatty liver disease
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
non alcoholic fatty liver disease. <br>Other specified inflammatory liver diseases;(K75.8);Other specified inflammatory liver diseases
|
| Interventions: |
Intervention 1: intervention group:2 gram citrulline per day for three months. Intervention 2: placebo group:2 gram starche per day for three months.;Treatment - Other;intervention group:2 gram citrulline per day for three months;placebo group:2 gram st
|
| Outcome Measures: |
LDL-C. Timepoint: Being andend of intervention. Method of measurement: Enzymatic methods using kits.;HDL-C. Timepoint: Being andend of intervention. Method of measurement: Enzymatic methods using kits.;TG. Timepoint: Being andend of intervention. Method of measurement: Enzymatic methods using kits.;Total Cholesterol. Timepoint: Being andend of intervention. Method of measurement: Enzymatic methods using kits.;FBS. Timepoint: Being andend of intervention. Method of measurement: Enzymatic methods using kits.;Fasting insulin. Timepoint: Being andend of intervention. Method of measurement: Radioimmunoassay ??U/mL.;AST. Timepoint: Being andend of intervention. Method of measurement: Enzymatic methods using kits.;ALT. Timepoint: Being andend of intervention. Method of measurement: Enzymatic methods using kits ??g/m.;HOMA. Timepoint: Being andend of intervention. Method of measurement: Calculation.;TNF-a. Timepoint: Being andend of intervention. Method of measurement: Elisa Pg/dl.;IL_6. Timepoint: Being andend of intervention. Method of measurement: Elisa Pg/dl.;Steatosis. Timepoint: Being andend of intervention. Method of measurement: Ultrasonography Grade 0: absence of steatosis grade 1: mild steatosis grade 2: moderate steatosis grade 3: severe steatosis.Total energy intake. Timepoint: Beginning and end of intervention. Method of measurement: questionnaire Kcal per day.;Carbohydrate intake. Timepoint: Beginning and end of intervention. Method of measurement: questionnaire gram per day.;Protein intake. Timepoint: Beginning and end of intervention. Method of measurement: questionnaire gram per day.;Total fat intake. Timepoint: Beginning and end of intervention. Method of measurement: questionnaire gram per day.;SAFA intake. Timepoint: Beginning and end of intervention. Method of measurement: questionnaire gram per day.;PUFA intake. Timepoint: Beginning and end of intervention. Method of measurement: questionnaire gram per day.;MUFA intake. Timepoint: Beginning and end of intervention. Method of measurement: questionnaire gram per day.;Total fiber intake. Timepoint: Beginning and end of intervention. Method of measurement: questionnaire gram per day.
|
| Sponsor/Collaborators: |
Shahid Beheshti University of Medical Sciences, National Nutrition and Food Technology Research
|
| Gender: |
All
|
| Age: |
no limitno limit
|
| Phases: |
Not applicable
|
| Enrollment: |
50
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.
|
| Start Date: |
13/10/2017
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
22 February 2018
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/4196
|
